Skip to main content
VCbacked
Log inGet Started

AbolerIS Pharma

Nantes, France

AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.

$29.2M raised
Sep 2023
Series A
Biotechnology

Top Investors

Sound BioventuresNewton BiocapitalSFPIMCriteria Bio VenturesSambrinvest

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AbolerIS Pharma

How much funding has AbolerIS Pharma raised?
AbolerIS Pharma has raised $29.2M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Who are AbolerIS Pharma's investors?
AbolerIS Pharma's investors include Sound Bioventures, Newton Biocapital, SFPIM, Criteria Bio Ventures, Sambrinvest.
Where is AbolerIS Pharma headquartered?
AbolerIS Pharma is headquartered in Nantes, France.
What does AbolerIS Pharma do?
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
What stage is AbolerIS Pharma at?
AbolerIS Pharma is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AbolerIS Pharma — Funding & Investors." VCBacked, September 18, 2023, https://www.vcbacked.co/company/aboleris-pharma. Accessed June 17, 2026.
APA
VCBacked. (2023). AbolerIS Pharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/aboleris-pharma
Wikipedia (cite web)
{{cite web |title=AbolerIS Pharma — Funding & Investors |url=https://www.vcbacked.co/company/aboleris-pharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong